A carregar...
Protective Effects of Li-Fei-Xiao-Yan Prescription on Lipopolysaccharide-Induced Acute Lung Injury via Inhibition of Oxidative Stress and the TLR4/NF-κB Pathway
Li-Fei-Xiao-Yan prescription (LFXY) has been clinically used in China to treat inflammatory and infectious diseases including inflammatory lung diseases. The present study was aimed at evaluating the potential therapeutic effects and potential mechanisms of LFXY in a murine model of lipopolysacchari...
Na minha lista:
Publicado no: | Evid Based Complement Alternat Med |
---|---|
Main Authors: | , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Hindawi
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5382312/ https://ncbi.nlm.nih.gov/pubmed/28424738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/1791789 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|